GUT：首次全面解析胰腺癌相关标志物的动态变化！( 三 )

非侵入性地及早诊断PDAC是提高治疗预后的核心关键，越早（能够在3年甚至5年前就触发警报）发现PDAC并及时干预治疗，就越能显著延长患者的生存期和提高生活质量，当然就能拯救更多患者的生命。 “胰”早不“胰”迟，此言非虚也。

文章图片
已购买课程的朋友，
直接进入小程序收听加餐哦~
【GUT：首次全面解析胰腺癌相关标志物的动态变化！】参考文献：
1.ChenW,ZhengR,BaadePD,etal.CancerstatisticsinChina,2015.CACancerJClin.2016;66(2):115-132.doi:10.3322/caac.21338.
2.MizrahiJD,SuranaR,ValleJW,ShroffRT.Pancreaticcancer.Lancet.2020;395(10242):2008-2020.doi:10.1016/S0140-6736(20)30974-0.
3.DboukM,KatonaBW,BrandRE,etal.TheMulticenterCancerofPancreasScreeningStudy:ImpactonStageandSurvival[publishedonlineaheadofprint,2022Jun15].JClinOncol.2022;JCO2200298.doi:10.1200/JCO.22.00298.
4.TanPS,GarrigaC,CliftA,etal.Temporalityofbodymassindex,bloodtests,comorbiditiesandmedicationuseasearlymarkersforpancreaticductaladenocarcinoma(PDAC):anestedcase-controlstudy[publishedonlineaheadofprint,2022Jun27].Gut.2022;gutjnl-2021-326522.doi:10.1136/gutjnl-2021-326522.
7.GrootVP,GemenetzisG,BlairAB,etal.DefiningandPredictingEarlyRecurrencein957PatientsWithResectedPancreaticDuctalAdenocarcinoma.AnnSurg.2019;269(6):1154-1162.doi:10.1097/SLA.0000000000002734.
8.KimJ,BamletWR,ObergAL,etal.Detectionofearlypancreaticductaladenocarcinomawiththrombospondin-2andCA19-9bloodmarkers.SciTranslMed.2017;9(398):eaah5583.doi:10.1126/scitranslmed.aah5583.
9.KartalE,SchmidtTSB,Molina-MontesE,etal.Afaecalmicrobiotasignaturewithhighspecificityforpancreaticcancer.Gut.2022;71(7):1359-1372.doi:10.1136/gutjnl-2021-324755.
11.AndersenDK,KorcM,PetersenGM,etal.Diabetes,PancreatogenicDiabetes,andPancreaticCancer.Diabetes.2017;66(5):1103-1110.doi:10.2337/db16-1477.
12.Hippisley-CoxJ,CouplandC.Developmentandvalidationofriskpredictionalgorithmstoestimatefutureriskofcommoncancersinmenandwomen:prospectivecohortstudy.BMJOpen.2015;5(3):e007825.Published2015Mar17.doi:10.1136/bmjopen-2015-007825.
13.OgawaY,TanakaM,InoueK,etal.Aprospectivepancreatographicstudyoftheprevalenceofpancreaticcarcinomainpatientswithdiabetesmellitus.Cancer.2002;94(9):2344-2349.doi:10.1002/cncr.10493.
责任编辑丨应雨妍